Hadassah

Hadassah’s Dr. Amal Bishara Receives “Outstanding Woman Scientist Award” from US Department of State

Thursday, Jan 31 2013

Dr. Amal Bishara, initiator and head of the Hadassah Medical Center's Arab Bone Marrow Registry Outreach Project, has been named "an outstanding woman scientist in the Middle East and North Africa" by the United States Department of State.

One of 13 women to receive this honor, Dr. Bishara was presented with the certificate pictured above in a ceremony at the residence of US Ambassador to Israel HE Daniel Shapiro.

Begun in 2008 as part of Hadassah's Tissue Typing Unit and Donor Registry, the Arab registry--the only one in the world—has 15,000 potential donors in its data base and has been responsible for 22 fully matching bone marrow transplants. For more about the Arab Donor Registry Project, see Saudi Arabian Media Puts Positive Spotlight on Hadassah Medical Center's Bone Marrow Registry

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, May 23 2018

From Legacy to Innovation: The Vision of Hadassah’s New Division of Nursing Director

Rely Alon, PhD, the new director of the Hadassah Medical Organization’s Division of Nursing and Health Professions, has a vision: “to bring Hadassah’s nurses to the forefront of leadership and to the spearhead of nursing in Israel.”

READ MORE ›
alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More